The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif

L Miguel Martins1, Ingram Iaccarino, Tencho Tenev

  • 1Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom.

Insights

The serine protease Omi/HtrA2 binds to XIAP, promoting apoptosis. Released from mitochondria during cell death, Omi/HtrA2 acts as a Reaper-like protein, sensitizing cells and reducing caspase inhibition.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting caspases.
  • Reaper proteins and Smac/DIABLO promote apoptosis by binding IAPs.
  • Understanding IAP regulation is crucial for controlling cell death pathways.

Purpose of the Study:

  • To identify novel mammalian proteins that interact with IAPs and modulate apoptosis.
  • To characterize the role of the serine protease Omi/HtrA2 in apoptosis regulation.
  • To elucidate the mechanism by which Omi/HtrA2 influences caspase activity.

Main Methods:

  • Yeast two-hybrid screening to identify XIAP-binding proteins.
  • Western blotting and immunoprecipitation to confirm protein interactions.
  • Confocal microscopy to determine subcellular localization.
  • RNA interference (RNAi) to assess the functional role of Omi/HtrA2.
  • Overexpression studies to evaluate Omi/HtrA2's impact on apoptosis.

Main Results:

  • Omi/HtrA2 was identified as a novel XIAP-binding protein with a Reaper-like motif.
  • Full-length Omi/HtrA2 localizes to mitochondria, while processed Omi/HtrA2 translocates to the cytosol upon apoptotic stimulus.
  • Processed Omi/HtrA2 interacts with XIAP in the cytosol, blocking its caspase-inhibitory function.
  • Overexpression of Omi/HtrA2 enhances apoptosis, whereas its depletion reduces cell death.

Conclusions:

  • Omi/HtrA2 is a second mammalian protein, alongside Smac/DIABLO, that antagonizes IAP function.
  • Omi/HtrA2 is released from mitochondria during apoptosis and promotes cell death by interacting with XIAP.
  • These findings expand the known repertoire of mitochondrial proteins that regulate apoptosis through IAP antagonism.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.